Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells - PubMed (original) (raw)
. 2006 Sep;318(3):1368-74.
doi: 10.1124/jpet.106.103747. Epub 2006 Jun 26.
Affiliations
- PMID: 16801455
- DOI: 10.1124/jpet.106.103747
Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells
Gökce Topal et al. J Pharmacol Exp Ther. 2006 Sep.
Erratum in
- J Pharmacol Exp Ther. 2006 Oct;319(1):506. Topal, Jean-Luc Gökce [corrected to Topal, Gökce]
Abstract
Reduced synthesis of nitric oxide (NO) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase (NOS) and cytosolic arginase I and mitochondrial arginase II. To determine whether arginases modulate the endothelial NO synthesis, we investigated the effects of the competitive arginase inhibitor N(omega)-hydroxy-nor-L-arginine (Nor-NOHA) on the activity of NOS, arginases, and L-arginine transporter and on NO release at surface of human umbilical vein endothelial cells (HUVECs). In unstimulated cells, Nor-NOHA dose-dependently reduced the arginase activity with maximal inhibition at 20 microM. When HUVECs were stimulated by thrombin without extracellular L-arginine, Nor-NOHA dose-dependently increased the NOS activity and the NO release with maximal effects at 20 microM. Extracellular L-arginine also dose-dependently increased NO release and arginase activity. When HUVECs were stimulated by thrombin in the presence of 100 microM L-arginine, NOS activity and NO release were similar in untreated and Nor-NOHA-treated cells. However, despite activation of L-arginine uptake, the inhibition of arginase activity by Nor-NOHA was still significant. The depletion of freely exchangeable L-arginine pools with extracellular L-lysine did not prevent Nor-NOHA from increasing the NO release. This indicates the presence of pools, which are accessible to NOS and arginase, but not exchangeable. Interestingly, the mitochondrial arginase II was constitutively expressed, whereas the cytosolic arginase I was barely detectable in HUVECs. These data suggest that endothelial NO synthesis depends on the activity of arginase II in mitochondria and l-arginine carriers in cell membrane.
Similar articles
- Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages.
Tenu JP, Lepoivre M, Moali C, Brollo M, Mansuy D, Boucher JL. Tenu JP, et al. Nitric Oxide. 1999 Dec;3(6):427-38. doi: 10.1006/niox.1999.0255. Nitric Oxide. 1999. PMID: 10637120 - Modulation of intrinsic cavernous tone and nitric oxide production by arginase in rabbit corpus cavernosum.
Masuda H, Yano M, Sakai Y, Kihara K, Yamauchi Y, Azuma H. Masuda H, et al. J Urol. 2004 Jan;171(1):490-4. doi: 10.1097/01.ju.0000088343.68746.65. J Urol. 2004. PMID: 14665961 - Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity.
Meurs H, Hamer MA, Pethe S, Vadon-Le Goff S, Boucher JL, Zaagsma J. Meurs H, et al. Br J Pharmacol. 2000 Aug;130(8):1793-8. doi: 10.1038/sj.bjp.0703488. Br J Pharmacol. 2000. PMID: 10952667 Free PMC article. - Arginase: a critical regulator of nitric oxide synthesis and vascular function.
Durante W, Johnson FK, Johnson RA. Durante W, et al. Clin Exp Pharmacol Physiol. 2007 Sep;34(9):906-11. doi: 10.1111/j.1440-1681.2007.04638.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17645639 Free PMC article. Review. - Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization.
Boucher JL, Moali C, Tenu JP. Boucher JL, et al. Cell Mol Life Sci. 1999 Jul;55(8-9):1015-28. doi: 10.1007/s000180050352. Cell Mol Life Sci. 1999. PMID: 10484661 Free PMC article. Review.
Cited by
- Arginine-dependent immune responses.
Martí I Líndez AA, Reith W. Martí I Líndez AA, et al. Cell Mol Life Sci. 2021 Jul;78(13):5303-5324. doi: 10.1007/s00018-021-03828-4. Epub 2021 May 26. Cell Mol Life Sci. 2021. PMID: 34037806 Free PMC article. Review. - Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment.
Hou X, Chen S, Zhang P, Guo D, Wang B. Hou X, et al. Front Oncol. 2022 Jul 11;12:938847. doi: 10.3389/fonc.2022.938847. eCollection 2022. Front Oncol. 2022. PMID: 35898872 Free PMC article. Review. - Arginase and vascular aging.
Santhanam L, Christianson DW, Nyhan D, Berkowitz DE. Santhanam L, et al. J Appl Physiol (1985). 2008 Nov;105(5):1632-42. doi: 10.1152/japplphysiol.90627.2008. Epub 2008 Aug 21. J Appl Physiol (1985). 2008. PMID: 18719233 Free PMC article. Review. - Apoptotic cell-derived factors induce arginase II expression in murine macrophages by activating ERK5/CREB.
Barra V, Kuhn AM, von Knethen A, Weigert A, Brüne B. Barra V, et al. Cell Mol Life Sci. 2011 May;68(10):1815-27. doi: 10.1007/s00018-010-0537-x. Epub 2010 Oct 15. Cell Mol Life Sci. 2011. PMID: 20949368 Free PMC article. - Characteristics and function of cardiac mitochondrial nitric oxide synthase.
Dedkova EN, Blatter LA. Dedkova EN, et al. J Physiol. 2009 Feb 15;587(Pt 4):851-72. doi: 10.1113/jphysiol.2008.165423. Epub 2008 Dec 22. J Physiol. 2009. PMID: 19103678 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials